The Predictive Value of 8-Hydroxy-Deoxyguanosine (8-OHdG) Serum Concentrations in Irradiated Non-Small Cell Lung Carcinoma (NSCLC) Patients.
Kyriakos OrfanakosConstantinos E AlifierisEmmanouil K VerigosMaria V DeligiorgiKosmas E VerigosMihalis I PanayiotidisMichail NikolaouDimitrios T TrafalisPublished in: Biomedicines (2024)
Ionizing radiation is strongly linked to direct or indirect DNA damage, as with the production of reactive oxygen species (ROS), which in turn produce DNA damage products, such as 8-hydroxy-2-deoxyguanosine (8-OHdG). In this study, we aimed to investigate the formation of 8-OHdG after irradiation in patients with non-small cell cancer (NSCLC) and its use as a biomarker. Sixteen patients with squamous and thirty-six patients with non-squamous pathology were included. An enzyme-linked-immunosorbent assay (ELISA) was performed before and after radiation. A dose-dependent relationship was confirmed: 8-OHdG plasma concentrations, increased in the total of NSCLC patients and specifically with a linear correlation in non-squamous pathology; in squamous histology, after an initial increase, a significant decrease followed after 20 Gy dose of irradiation. The pretreatment total irradiated tumor volume (cm 3 ) was positively correlated with 8-OHdG levels in patients with squamous histology. When plotting the 8-OHdG plasma concentration at a 10 Gy irradiation dose to the baseline, the AUC was 0.873 (95% CI 0.614-0.984), p < 0.0001, with an associated criterion value of >1378 as a cutoff (sensitivity 72.7%, specificity 100%). When normalizing this ratio to BSA, the associated criterion cutoff value was >708 (sensitivity of 100%, specificity 80%). Lastly, 8-OHdG levels were closely related with the development of radiation-induced toxicities.
Keyphrases
- dna damage
- radiation induced
- high grade
- end stage renal disease
- small cell lung cancer
- reactive oxygen species
- low grade
- ejection fraction
- newly diagnosed
- oxidative stress
- chronic kidney disease
- prognostic factors
- single cell
- radiation therapy
- peritoneal dialysis
- cell therapy
- squamous cell carcinoma
- dna repair
- advanced non small cell lung cancer
- stem cells
- high throughput
- patient reported outcomes
- young adults
- papillary thyroid
- drug induced